AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2026)

AdaptHealth's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $59.7 million for Q1 2026.

• On a quarterly basis, Current Deferred Revenue rose 28.59% year-over-year to $59.7 million in Q1 2026; TTM through Mar 2026 was $59.7 million, a 28.59% increase from a year earlier, with the FY2025 full-year figure at $59.8 million, up 71.25% from the prior year.
• Current Deferred Revenue steadied at $59.7 million in Q1 2026 per AHCO's latest filing, from $59.8 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $59.9 million in Q3 2025 and bottomed at $30.6 million in Q1 2022.
• The 5-year median for Current Deferred Revenue is $35.8 million (2024), against an average of $41.3 million.
• Across the five-year window, Current Deferred Revenue retreated 25.3% in 2024 and surged 71.25% in 2025, its largest moves.
• Year by year, Current Deferred Revenue stood at $31.6 million in 2022, then increased by 21.9% to $38.6 million in 2023, then fell by 9.4% to $34.9 million in 2024, then jumped by 71.25% to $59.8 million in 2025, then declined by 0.19% to $59.7 million in 2026.
• Per Business Quant, the three latest AHCO Current Deferred Revenue figures stand at $59.7 million (Q1 2026), $59.8 million (Q4 2025), and $59.9 million (Q3 2025).